Asensio Lopez, M. D. C., Lax, A., Hernandez Vicente, A., Saura Guillen, E., Hernandez-Martinez, A., Fernandez Del Palacio, M. J., . . . Pascual-Figal, D. A. (2020). Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status.
Citación estilo ChicagoAsensio Lopez, Maria Del Carmen, Antonio Lax, Alvaro Hernandez Vicente, Elena Saura Guillen, Antonio Hernandez-Martinez, Maria Josefa Fernandez Del Palacio, Antoni Bayes-Genis, y Domingo A. Pascual-Figal. Empagliflozin Improves Post-infarction Cardiac Remodeling Through GTP Enzyme Cyclohydrolase 1 and Irrespective of Diabetes Status. 2020.
Cita MLAAsensio Lopez, Maria Del Carmen, et al. Empagliflozin Improves Post-infarction Cardiac Remodeling Through GTP Enzyme Cyclohydrolase 1 and Irrespective of Diabetes Status. 2020.